Don’t judge the quarter too quickly

The one-two punch of strong earnings and tame inflation helped propel the S & P 500 to a positive week — despite the latest tariff news on Friday putting a slight damper on the action. The broad index added 0.59% for the week led by technology, utilities and industrials, while the tech-heavy Nasdaq outperformed, jumping…

Read More

‘A little bit of an overreaction’

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim Cramer, saying that Wall Street’s reaction to the results was extreme. “I think this is a little bit of an overreaction. Of course, we are all over this,” Ford said. “We’re focused on this, but the fundamentals…

Read More

It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results,…

Read More